ACQUISITION OF MEDICINAL AND PHARMACEUTICAL PRODUCTS FOR THE NATIONAL UNIT FOR THE CARE OF CHRONIC RENAL PATIENTS - UNAERC UNAERC/L01/2023

This tender concerns the procurement of essential medicinal and pharmaceutical products for the National Unit for the Care of Chronic Renal Patients (UNAERC). The specific items required include Meropenem for injection (500 mg), Vancomycin Hydrochloride lyophilized powder for injection (500 mg vial), Irbesartan (300 mg), Carvedilol tablets (12.5 mg), Ceftazidime powder for injection (1 gram), and Hypertonic Dextrose solution (30% in 250 ml). The procurement method specified is Public Tender, in accordance with Article 17 of the Public Procurement Law (LCE). The contracting entity is the National Unit for the Care of Chronic Renal Patients (UNAERC). This tender is currently in an unawarded status. The objective is to ensure a consistent and adequate supply of these critical medications to support the treatment and management of patients suffering from chronic kidney disease. UNAERC plays a vital role in providing specialized care for this patient population, and the availability of these pharmaceuticals is paramount to their ongoing healthcare services. Interested parties are invited to review the tender documents for detailed specifications and submission requirements. The tender aims to secure high-quality pharmaceutical products from reliable suppliers to meet the clinical needs of the patients under UNAERC's care.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and Laboratory. Located in Guatemala, Latin America, this opportunity is open to firms and consortiums.

Published through Guatecompras, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.